Results 1 to 10 of about 5,590 (241)

Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021) [PDF]

open access: yesActa Obstetricia et Gynecologica Scandinavica
Introduction Exposure to potentially teratogenic medications during pregnancy is underinvestigated in Switzerland. We aimed to assess exposure to potential teratogens preconceptionally, during the first trimester, and in women of childbearing age, and ...
Carole A. Marxer   +5 more
doaj   +2 more sources

Implementing a trilineage differentiation in the ReproTracker assay for improved teratogenicity assessment [PDF]

open access: yesFrontiers in Toxicology
IntroductionExposure to teratogenic compounds during pregnancy can lead to significant birth defects. Given the considerable variation in drug responses across species, along with the financial and ethical challenges associated with animal testing, the ...
José M. Horcas-Nieto   +11 more
doaj   +2 more sources

Comparative analysis of teratogen-induced malformations and gene expression across zebrafish strains in early development [PDF]

open access: yesToxicology Reports
Zebrafish embryos are widely used in developmental toxicity testing. However, the extent to which genetic background influences susceptibility to teratogenic compounds remains incompletely understood.
Chitose Taya   +6 more
doaj   +2 more sources

Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells

open access: yesCell Death Discovery, 2023
Summary Animal studies for embryotoxicity evaluation of potential therapeutics and environmental factors are complex, costly, and time-consuming. Often, studies are not of human relevance because of species differences.
Anna Cherianidou   +11 more
doaj   +1 more source

Association between Genetic Variants in NOS2 and TNF Genes with Congenital Zika Syndrome and Severe Microcephaly

open access: yesViruses, 2021
Zika virus (ZIKV) causes Congenital Zika Syndrome (CZS) in individuals exposed prenatally. Here, we investigated polymorphisms in VEGFA, PTGS2, NOS3, TNF, and NOS2 genes as risk factors to CZS. Forty children with CZS and forty-eight children who were in
Julia A. Gomes   +11 more
doaj   +1 more source

Pregnancy and neonatal outcomes after periconceptional exposure to isotretinoin in Koreans [PDF]

open access: yesObstetrics & Gynecology Science, 2022
Objective Isotretinoin should not be used during pregnancy because of the risk of birth defects. Most pregnant women exposed to isotretinoin choose voluntary pregnancy termination due to concerns about birth defects.
Eun-Hwan Cha   +9 more
doaj   +1 more source

A standardized human embryoid body platform for the detection and analysis of teratogens. [PDF]

open access: yesPLoS ONE, 2017
Teratogens are compounds that can induce birth defects upon exposure of the developing fetus. To date, most teratogen studies utilize pregnant rodents to determine compound teratogenicity in vivo.
Anthony Flamier   +2 more
doaj   +1 more source

Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review

open access: yesFrontiers in Genetics, 2021
Since the 1960s, drugs have been known to cause teratogenic effects in humans. Such teratogenicity has been postulated to be influenced by genetics. The aim of this review was to provide an overview of the current knowledge on genetic susceptibility to ...
Julia do Amaral Gomes   +22 more
doaj   +1 more source

Functional Polymorphisms in the p53 Pathway Genes on the Genetic Susceptibility to Zika Virus Teratogenesis

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Congenital Zika Syndrome (CZS) occurs in up to 42% of individuals exposed to ZIKV prenatally. Deregulation in gene expression and protein levels of components of the p53 signaling pathway, such as p53 and MDM2, due to ZIKV infection has been reported ...
Julia A. Gomes   +26 more
doaj   +1 more source

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies

open access: yesFrontiers in Pharmacology, 2023
Background: Exposure in utero to certain medications can disrupt processes of fetal development, including brain development, leading to a continuum of neurodevelopmental difficulties.
R. L. Bromley   +31 more
doaj   +1 more source

Home - About - Disclaimer - Privacy